The Society for Pediatric Dermatology (SPD) is the only national organization in the United States specifically dedicated to the field of Pediatric Dermatology.
The Society's objective is to promote, develop, and advance education, research, and care of skin disease in all pediatric age groups. The organization holds meetings twice a year to educate physicians about advances in pediatric dermatology, help them support children with dermatological diseases, and improve their care.
What’s New
-
2020 Pediatric Dermatology Compensation and Productivity Report Out Now
This report features the single largest data set of compensation and production information for pediatric dermatologists in the history of the specialty and provides important benchmarks for current and future physicians. It also represents the first report for pediatric dermatology physicians since 2014.
-
COVID-19 Resources for Patients and Caregivers
The SPD has released helpful information for patients, families, and practitioners to navigate the pandemic, including a Teledermatology patient handout in English and Spanish. Plus, a COVID-19 Vaccine for Pediatric Populations handout is coming out soon.
-
Spring 2021 PediDerm Pulse Newsletter
Featuring: President's Message, PeDRA Update, Research Corner, Funding Opportunities, Literature Review, Mentoring Moment, + more. The SPD's newsletter, PediDerm Pulse, can be found in the Members Only Area.
-
Vaccine Considerations in Pediatric Populations Patient Handout
SPD offers a series of handouts aimed at providing reliable information to medical providers, patients, and families alike. Vaccine Considerations in Pediatric Populations is the 41st handout to be added to our Patient Perspectives library. Download the file in English and/or Spanish to use in your practice.
Latest Articles in Pediatric Dermatology
-
Hair at the intersection of dermatology and anthropology: A conversation on race and relationships
-
Persistent dysesthesias in involuted infantile hemangiomas: An uncommon complication in a common condition
-
Tools to study the severity of itch in 8‐ to 17‐year‐old children: Validation of TweenItchyQoL and ItchyQuant
-
Rapid response to secukinumab in a 5‐year‐old with deficiency of the interleukin‐36 receptor antagonist (DITRA) with severe scalp and nail involvement
-
Perinatal‐lethal Gaucher disease presenting with blueberry muffin lesions
Follow Us:
Copyright © 2021 | The Society for Pediatric Dermatology